GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Accounts Payable & Accrued Expense

3SBio (TRSBF) Accounts Payable & Accrued Expense : $86 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is 3SBio Accounts Payable & Accrued Expense?

3SBio's quarterly accounts payable & accrued expense increased from Dec. 2022 ($92 Mil) to Jun. 2023 ($119 Mil) but then declined from Jun. 2023 ($119 Mil) to Dec. 2023 ($86 Mil).

3SBio's annual accounts payable & accrued expense declined from Dec. 2021 ($100 Mil) to Dec. 2022 ($92 Mil) and declined from Dec. 2022 ($92 Mil) to Dec. 2023 ($86 Mil).

3SBio Accounts Payable & Accrued Expense Historical Data

The historical data trend for 3SBio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Accounts Payable & Accrued Expense Chart

3SBio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.39 86.75 99.98 92.02 86.02

3SBio Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.98 149.91 92.02 118.90 86.02

3SBio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

3SBio (TRSBF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
HKSE:06826 HKSE:06990 HKSE:02162 HKSE:09688 HKSE:09969 HKSE:01541 HKSE:06660 HKSE:09966 HKSE:01952 HKSE:02315 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
01530:Hong Kong 83B:Germany
Address
No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027
Website
https://www.3sbio.com
3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines